Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label, multi-center study

• Main Authors: Franco M. Piazza (Author), Miia Virta (Author), Marita Paassilta (Author), Benita Ukkonen (Author), Anitta Ahonen (Author), Alejandra Esteves-Jaramillo (Author), Aino Forsten (Author), Ilkka Seppa (Author), Jian Ding (Author), David Neveu (Author), Emilia Jordanov (Author), Mandeep S. Dhingra (Author)
• Format: Book
• Published: Taylor & Francis Group, 2022-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Booster doses of meningococcal conjugate vaccines induce long-term protection against invasive meningococcal disease. We evaluated the immunogenicity and safety of a booster dose of MenACYW-TT in pre-school children who were primed 3 years earlier with MenACYW-TT or MCV4-TT (Nimenrix®). In this Phas...